Clinical Trial Update: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating PET imaging of cyclooxygenases in neurodegenerative brain diseases, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amyotrophic Lateral Sclerosis
• Cognitive Impairment
• Dementia
• Parkinson Disease

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Parkinson's Disease, Dementia | Phase 1 | Status: RECRUITING